Cargando…
A new blood-based RNA signature (R(9)), for monitoring effectiveness of tuberculosis treatment in a South Indian longitudinal cohort
Tuberculosis (TB) treatment involves a multidrug regimen for six months, and until two months, it is unclear if treatment is effective. This delay can lead to the evolution of drug resistance, lung damage, disease spread, and transmission. We identify a blood-based 9-gene signature using a computati...
Autores principales: | Thakur, Chandrani, Tripathi, Ashutosh, Ravichandran, Sathyabaarathi, Shivananjaiah, Akshatha, Chakraborty, Anushree, Varadappa, Sreekala, Chikkavenkatappa, Nagaraj, Nagarajan, Deepesh, Lakshminarasimhaiah, Sharada, Singh, Amit, Chandra, Nagasuma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800112/ https://www.ncbi.nlm.nih.gov/pubmed/35118358 http://dx.doi.org/10.1016/j.isci.2022.103745 |
Ejemplares similares
-
Ω76: A designed antimicrobial peptide to combat carbapenem- and tigecycline-resistant Acinetobacter baumannii
por: Nagarajan, Deepesh, et al.
Publicado: (2019) -
VB(10), a new blood biomarker for differential diagnosis and recovery monitoring of acute viral and bacterial infections
por: Ravichandran, Sathyabaarathi, et al.
Publicado: (2021) -
PLIC: protein–ligand interaction clusters
por: Anand, Praveen, et al.
Publicado: (2014) -
ABS–Scan:
In silico alanine scanning mutagenesis for binding site residues in protein–ligand complex
por: Anand, Praveen, et al.
Publicado: (2014) -
Mycobacterium tuberculosis requires SufT for Fe-S cluster maturation, metabolism, and survival in vivo
por: Tripathi, Ashutosh, et al.
Publicado: (2022)